Abandoned: the human cost of neurotechnology failure
The implant was a revelation. After the pattern and strength of the stimulation had been tailored to Möllmann-Bohle’s needs, around an hour’s use five or six times a day was enough to prevent attacks from becoming debilitating. “I was reborn,” he says.But, by the end of 2019, ATI had collapsed. The company’s closure left Möllmann-Bohle…